(Q41432704)

30 September 2017

Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis (English)

1 reference

30 September 2017

1 reference

1 reference

1 reference

4

Hennekens CH

1 reference

30 September 2017

2

Buring JE

1 reference

30 September 2017

S. Z. Goldhaber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6367454

9 October 2023

R. J. Lipnick

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6367454

9 October 2023

language of work or name

English

0 references

publication date

1 March 1984

1 reference

full work available at URL

30 September 2017

https://api.elsevier.com/content/article/PII:0002934384906569?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

https://api.elsevier.com/content/article/PII:0002934384906569?httpAccept=text/plain

9 October 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

American Journal of Medicine

9 October 2023

published in

1 reference

30 September 2017

76

1 reference

30 September 2017

3

1 reference

30 September 2017

393-397

1 reference

Treatment of Deep Vein Thrombosis. A Trial of Heparin, Streptokinase, and Arvin

30 September 2017

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

Thrombolytic effect of streptokinase as evaluated by phlebography of deep venous thrombi of the leg

9 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

Controlled study of thrombolytic therapy in deep vein thrombosis

9 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

Comparison of heparin and streptokinase in the treatment of venous thrombosis

9 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: An interim report of a prospective trial

9 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

Streptokinase and Deep Vein Thrombosis

9 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

Treatment of deep vein thrombosis with streptokinase

9 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy

9 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

A Prospective Study of Streptokinase and Heparin in the Treatment of Deep Vein Thrombosis

9 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis. A comparative study between streptokinase and heparin therapy

9 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

Estimability and estimation in case-referent studies

9 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

Combination of log relative risk in retrospective studies of disease

9 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

Deep vein thrombosis treated with streptokinase or heparin. Follow-up of a randomized study

9 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

Comparison of Streptokinase with Heparin: Late Results in the Treatment of Deep Venous Thrombosis

9 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials

9 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials

9 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

9 October 2023

Thrombolytic therapy

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

The maintenance of a sustained thrombolytic state in man. I. Induction and effects

9 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(84)90656-9

9 October 2023

Identifiers

1 reference

30 September 2017

1 reference